MUKILTEO, Wash., Feb. 26, 2009 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) today announced positive preliminary data on its investigational Comprehensive Cancer Array (CCA) test showing it can non-invasively screen for the early detection of cancer. The study focused on prostate, colon, ovarian, breast, and lung cancers, as these five cancers comprise roughly 85% of all solid tumors in the United States. The results were presented at Cambridge Healthtech Institute's 16th International Molecular Medicine Tri-Conference being held February 25-27, 2009, in San Francisco.
